Our experienced team of infectious disease specialists will be on hand to discuss your Phase I-IV drug development programs and answer any questions you might have about our global capabilities.
AAIPharma has extensive experience conducting Phase I-IV clinical trials for many of the most prevalent and dangerous infectious diseases worldwide. Augmented by our knowledge of emerging vaccine development, infectious disease is a core focus of our biological and pharmaceutical clinical development programs.
Among the therapeutic areas in which we have conducted clinical trials include:
- Pneumonia
- Human Papillomavirus
- Sepsis
- Gastroenteritis Rotavirus
- Influenza
- Helicobacter Pylori
- West Nile Virus
- Respiratory
- HIV/AIDS
- Herpes
- Hepatitis
- Rabies
- Smallpox
- Skin
- Malaria
- Fever
To schedule a meeting during conference, contact Terri Anthony at 919.466.3326 or email terry.anthony@aaipharma.com.
